Pantoprazole Aurobindo Pharma (Malta)

Pantoprazole, the active ingredient in Pantoprazole Aurobindo Pharma (Malta), is a proton pump inhibitor presented as a tablet for oral use. It belongs to the therapeutic class of gastrointestinal acid‑reduction therapy and is marketed in the European Union for the treatment of acid‑related disorders in adults.

GNH USA supplies Pantoprazole Aurobindo Pharma (Malta) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to GMP standards and regulatory‑compliant distribution.

Pantoprazole is a proton pump inhibitor used to manage conditions involving excess gastric acid production. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the esophageal lining. - Erosive esophagitis: facilitates mucosal repair by maintaining a higher gastric pH. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid in this rare endocrine disorder.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools without blood. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Liver enzyme elevation: abnormal liver function tests.

Before initiating therapy, consider the following precautions. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: monitor liver enzymes in patients with liver disease. - Review concomitant medications: potential for drug‑drug interactions. - Use with caution in elderly: higher incidence of fractures and infections. - Pregnancy and lactation: only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Pantoprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy. - Atazanavir or other protease inhibitors: decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Methotrexate (high dose): reduced clearance, watch for toxicity. - Digoxin: slight increase in serum levels, assess clinical response. - Oral contraceptives: potential decrease in effectiveness, advise backup method.